» Articles » PMID: 39795977

The Molecular Basis of Asthma Exacerbations Triggered by Viral Infections: The Role of Specific MiRNAs

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2025 Jan 11
PMID 39795977
Authors
Affiliations
Soon will be listed here.
Abstract

Viral respiratory infections are a significant clinical problem among the pediatric population and are one of the leading causes of hospitalization. Most often, upper respiratory tract infections are self-limiting. Still, those that involve the lower respiratory tract are usually associated with asthma exacerbations, leading to worsening or even the initiation of the disease. A key role in regulating the immune response and inflammation during viral infections and their impact on the progression of asthma has been demonstrated for miRNA molecules (microRNA). Their interaction with mRNA (messenger RNA) regulates gene expression in innate and acquired immune responses, making them valuable biomarkers for diagnostics, monitoring, and predicting asthma exacerbations. The following paper presents changes in the expression of miRNAs during the five most common viral infections causing asthma worsening, with particular emphasis on the pediatric population. In addition, we describe the molecular mechanisms by which miRNAs influence the pathogenesis of viral infection, immune responses, and asthma exacerbations. These molecules represent promising targets for future innovative therapeutic strategies, paving the way for developing personalized medicine for patients with viral-induced asthma exacerbations.

References
1.
Makrinioti H, Hasegawa K, Lakoumentas J, Xepapadaki P, Tsolia M, Castro-Rodriguez J . The role of respiratory syncytial virus- and rhinovirus-induced bronchiolitis in recurrent wheeze and asthma-A systematic review and meta-analysis. Pediatr Allergy Immunol. 2022; 33(3):e13741. DOI: 10.1111/pai.13741. View

2.
Wardzynska A, Pawelczyk M, Rywaniak J, Makowska J, Kowalski M, Chalubinski M . miRNA expression in serum and PBMCs isolated from middle-aged and elderly patients during asthma exacerbation. APMIS. 2023; 131(7):369-377. DOI: 10.1111/apm.13328. View

3.
Nayak J, Hoy G, Gordon A . Influenza in Children. Cold Spring Harb Perspect Med. 2019; 11(1). PMC: 7778215. DOI: 10.1101/cshperspect.a038430. View

4.
Kyo M, Zhu Z, Shibata R, Ooka T, Mansbach J, Harmon B . Nasal microRNA signatures for disease severity in infants with respiratory syncytial virus bronchiolitis: a multicentre prospective study. BMJ Open Respir Res. 2024; 11(1). PMC: 11293419. DOI: 10.1136/bmjresp-2023-002288. View

5.
Wu W, Wang C, Xia C, Liu S, Mei Q . MicroRNA let-7 Suppresses Influenza A Virus Infection by Targeting RPS16 and Enhancing Type I Interferon Response. Front Cell Infect Microbiol. 2022; 12:904775. PMC: 9301362. DOI: 10.3389/fcimb.2022.904775. View